Quince Therapeutics (Legacy Small Molecule Protease Inhibitor Portfolio in California) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Quince Therapeutics (Legacy Small Molecule Protease Inhibitor Portfolio in California) General Information

Description

Legacy small molecule protease inhibitor portfolio based in South San Francisco, California.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • South San Francisco, CA
  • United States
Primary Industry
Buildings and Property
Acquirer
Lighthouse Pharma
Corporate Office
  • South San Francisco, CA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Quince Therapeutics (Legacy Small Molecule Protease Inhibitor Portfolio in California) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Quince Therapeutics (Legacy Small Molecule Protease Inhibitor Portfolio in California)‘s full profile, request access.

Request a free trial

Quince Therapeutics (Legacy Small Molecule Protease Inhibitor Portfolio in California) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Quince Therapeutics (Legacy Small Molecule Protease Inhibitor Portfolio in California)‘s full profile, request access.

Request a free trial

Quince Therapeutics (Legacy Small Molecule Protease Inhibitor Portfolio in California) FAQs

  • Where is Quince Therapeutics (Legacy Small Molecule Protease Inhibitor Portfolio in California) headquartered?

    Quince Therapeutics (Legacy Small Molecule Protease Inhibitor Portfolio in California) is headquartered in South San Francisco, CA.

  • What industry is Quince Therapeutics (Legacy Small Molecule Protease Inhibitor Portfolio in California) in?

    Quince Therapeutics (Legacy Small Molecule Protease Inhibitor Portfolio in California)’s primary industry is Buildings and Property.

  • Is Quince Therapeutics (Legacy Small Molecule Protease Inhibitor Portfolio in California) a private or public company?

    Quince Therapeutics (Legacy Small Molecule Protease Inhibitor Portfolio in California) is a Private company.

  • What is the current valuation of Quince Therapeutics (Legacy Small Molecule Protease Inhibitor Portfolio in California)?

    The current valuation of Quince Therapeutics (Legacy Small Molecule Protease Inhibitor Portfolio in California) is .

  • What is Quince Therapeutics (Legacy Small Molecule Protease Inhibitor Portfolio in California)’s current revenue?

    The current revenue for Quince Therapeutics (Legacy Small Molecule Protease Inhibitor Portfolio in California) is .

  • Who are Quince Therapeutics (Legacy Small Molecule Protease Inhibitor Portfolio in California)’s investors?

    IRulya Therapeutics has invested in Quince Therapeutics (Legacy Small Molecule Protease Inhibitor Portfolio in California).

  • When was Quince Therapeutics (Legacy Small Molecule Protease Inhibitor Portfolio in California) acquired?

    Quince Therapeutics (Legacy Small Molecule Protease Inhibitor Portfolio in California) was acquired on 27-Jan-2023.

  • Who acquired Quince Therapeutics (Legacy Small Molecule Protease Inhibitor Portfolio in California)?

    Quince Therapeutics (Legacy Small Molecule Protease Inhibitor Portfolio in California) was acquired by Lighthouse Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process